CCM
IDXX icon

Cinctive Capital Management’s Idexx Laboratories IDXX Stock Holding History

Cinctive Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,942
Closed -$1.63M – 389
2024
Q4 		$1.63M Buy
3,942
+622
+19% +$273K 0.08% 239
2024
Q3 		$1.68M Buy
+3,320
New +$1.61M 0.09% 248
2022
Q2 		– Sell
-3,879
Closed -$2.12M – 560
2022
Q1 		$2.12M Buy
+3,879
New +$2.04M 0.08% 320

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cinctive Capital Management's IDXX Position: Q1 2025 in Review

Cinctive Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 3,942 shares — an estimated $1.63M sold.

Cinctive Capital Management first reported a position in IDXX in Q1 2022 and held it in 3 quarters. The position peaked at $2.12M in Q1 2022. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Cinctive Capital Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 3,942 Idexx Laboratories shares in Q1 2025, an estimated $1.63M.
  • Cinctive Capital Management first reported a position in Idexx Laboratories in Q1 2022 and held it in 3 quarters.
  • Cinctive Capital Management's Idexx Laboratories position peaked at $2.12M in Q1 2022.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.